Drug intelligence / Profile preview

gamma-tocotrienol

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical, Intravenous
01

Overview

Gamma-tocotrienol is one of the four naturally occurring tocotrienols (alpha, beta, gamma, delta), which are members of the vitamin E family. It is a lipid-soluble compound found in sources such as palm oil and rice bran oil. Gamma-tocotrienol exhibits potent antioxidant properties by neutralizing free radicals and protecting cells from oxidative damage. Its lipophilic nature allows it to integrate into cell membranes, stabilizing them and preventing lipid peroxidation. In addition to its antioxidant effects, gamma-tocotrienol modulates cellular pathways involved in inflammation and apoptosis (programmed cell death), contributing to potential benefits in cardiovascular health, neuroprotection, skin health, and cancer prevention or therapy[1][4][5][8]. Preclinical studies suggest that it can downregulate enzymes involved in fatty acid synthesis (such as fatty acid synthase) and upregulate enzymes promoting fatty acid oxidation (such as carnitine palmitoyltransferase 1A)[6]. Gamma- and delta-tocotrienols have shown particular promise for anticancer activity by inhibiting proliferation of cancer cells, inducing apoptosis, suppressing metastasis, and modulating key signaling pathways[8]. While widely used as a dietary supplement for general wellness or specific conditions like cardiovascular disease or neurodegeneration[5], robust clinical evidence supporting these uses remains limited.

Other names
γ-tocotrienolgamma-T3gamma-T-3gamma-T 3
02

Targets

FASN (Fatty acid synthase)SREBP-1 / SREBF1 (SREBP-1)

Beyond the preview

Go deeper on gamma-tocotrienol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gamma-tocotrienol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call